Henry Weinstein is a seasoned science and technology investor currently serving as a Science & Tech Investor at Laniakea LLC and as Chairman at both NextHen and Medismart Live. Previously, they held various leadership roles, including Vice President of Strategy and Innovation at Abbott and Head of Biologics Business Development at CFR Pharmaceuticals. Henry served on the board of CONSORCIO TECNOLÓGICO EN BIOMEDICINA CLÍNICO-MOLECULAR S.A. from 2012 to 2016 and has been an Investment Principal at OTV since 2017. They hold a Bachelor of Arts in International Business from the European Business School and a Certificate of Professional Development in Finance from The Wharton School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices